Evolent Health, Inc. (EVH)
NYSE: EVH · Real-Time Price · USD
3.040
-0.130 (-4.10%)
At close: Mar 9, 2026, 4:00 PM EDT
3.070
+0.030 (0.99%)
After-hours: Mar 9, 2026, 7:31 PM EDT

Evolent Health Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
3394461,2943,7972,7982,431
Upgrade
Market Cap Growth
-72.81%-65.50%-65.92%35.70%15.09%79.91%
Upgrade
Enterprise Value
1,1771,4122,0204,4423,1192,481
Upgrade
Last Close Price
3.044.0011.2533.0328.0827.67
Upgrade
Forward PE
17.7116.8813.6638.4044.32-
Upgrade
PS Ratio
0.180.240.511.932.072.68
Upgrade
PB Ratio
0.821.081.093.053.263.51
Upgrade
P/FCF Ratio
71.3793.88-33.36-216.09
Upgrade
P/OCF Ratio
8.7411.4968.9626.63-62.75
Upgrade
EV/Sales Ratio
0.630.750.792.262.312.73
Upgrade
EV/EBITDA Ratio
13.3416.0121.2440.05153.52153.84
Upgrade
EV/EBIT Ratio
--84.36313.22--
Upgrade
EV/FCF Ratio
247.58296.96-39.02-220.47
Upgrade
Debt / Equity Ratio
2.382.380.600.520.550.40
Upgrade
Debt / EBITDA Ratio
10.6910.696.905.1613.628.21
Upgrade
Debt / FCF Ratio
208.14208.14-5.66-24.93
Upgrade
Net Debt / Equity Ratio
2.022.020.510.360.340.02
Upgrade
Net Debt / EBITDA Ratio
9.509.506.414.0814.170.88
Upgrade
Net Debt / FCF Ratio
176.20176.20-42.463.97-4.871.26
Upgrade
Asset Turnover
0.840.840.980.870.840.65
Upgrade
Quick Ratio
1.201.200.730.951.020.89
Upgrade
Current Ratio
1.311.310.851.011.101.18
Upgrade
Return on Equity (ROE)
-66.54%-66.54%-5.06%-10.74%-2.41%-4.61%
Upgrade
Return on Assets (ROA)
-0.13%-0.13%0.57%0.39%-0.77%-0.78%
Upgrade
Return on Invested Capital (ROIC)
-0.29%-0.29%1.37%1.00%-2.14%-2.54%
Upgrade
Return on Capital Employed (ROCE)
-0.30%-0.30%1.30%0.70%-1.40%-1.80%
Upgrade
Earnings Yield
-170.72%-119.74%-4.76%-2.98%-0.69%-1.55%
Upgrade
FCF Yield
1.40%1.06%-1.11%3.00%-2.11%0.46%
Upgrade
Buyback Yield / Dilution
0.41%0.41%-3.08%-18.73%-8.87%-1.34%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.